.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
Fuji
Medtronic
Farmers Insurance
Harvard Business School
Accenture
Deloitte
Cantor Fitzgerald
AstraZeneca

Generated: June 25, 2017

DrugPatentWatch Database Preview

DOXAPRAM HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Doxapram Hydrochloride, and what generic Doxapram Hydrochloride alternatives are available?

Doxapram Hydrochloride is a drug marketed by Watson Labs and Athenex Inc and is included in two NDAs.

The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxapram hydrochloride profile page.

Summary for Tradename: DOXAPRAM HYDROCHLORIDE

Patents:0
Applicants:2
NDAs:2
Bulk Api Vendors: see list22
Clinical Trials: see list2,251
Patent Applications: see list144
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXAPRAM HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
DOXAPRAM HYDROCHLORIDE
doxapram hydrochloride
INJECTABLE;INJECTION073529-001Jan 30, 1992DISCNNoNo► Subscribe► Subscribe
Athenex Inc
DOXAPRAM HYDROCHLORIDE
doxapram hydrochloride
INJECTABLE;INJECTION076266-001Jan 10, 2003APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Fish and Richardson
Mallinckrodt
Cantor Fitzgerald
Moodys
Cipla
Medtronic
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot